It has however been suggested that clarithromycin “suppresses infection-related inflammation and reduces vascular hyper-permeability by suppressing the induction of monocyte chemoattractant protein-1 (MCP-1) and matrix metalloproteinases-9 (MMP-9)” [24]. The gene discussed is MMP9; the disease is infection.